Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PBF-680 in mild-to-moderate persistent atopic asthma
NCT03774290Phase 2Completed
- Sponsor
- Palobiofarma
- Start
- Jun 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PBF-680 in asthma, sponsored by Palobiofarma. Started Jun 2018; status: completed.
02
Drugs
PBF-680
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03774290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03774290.